SORBS2 as a molecular target for atherosclerosis in patients with familial hypercholesterolemia.

Ming-Ming LiuJia PengYuan-Lin GuoCheng-Gang ZhuNa-Qiong WuRui-Xia XuQian DongChuan-Jue CuiJian-Jun Li

Published in: Journal of translational medicine (2022)

SORBS2 regulates lipid-induced inflammation and foam cell formation, and is a potential therapeutic target for hypercholesterolemia.

Keyphrases